Published in Arch Intern Med on August 11, 2008
Exercise Training After an Acute Blood Clot (TRAIN ABC) | NCT01864447
Noncardiac vascular disease in rheumatoid arthritis: increase in venous thromboembolic events? Arthritis Rheum (2012) 1.34
Portal vein thrombosis following laparoscopic sleeve gastrectomy for morbid obesity. JSLS (2013) 1.16
Risk of venous thromboembolism and myocardial infarction associated with factor V Leiden and prothrombin mutations and blood type. CMAJ (2013) 1.16
Efficacy and safety of high-dose thromboprophylaxis in morbidly obese inpatients. Thromb Haemost (2013) 1.08
Epidemiology of venous thromboembolism. Nat Rev Cardiol (2015) 1.07
Effect of extremes of body weight on the pharmacokinetics, pharmacodynamics, safety and tolerability of apixaban in healthy subjects. Br J Clin Pharmacol (2013) 1.05
The epidemiology of venous thromboembolism. J Thromb Thrombolysis (2016) 1.00
Quantification of hypercoagulable state after blunt trauma: microparticle and thrombin generation are increased relative to injury severity, while standard markers are not. Surgery (2012) 0.99
Prevention of venous thromboembolism in obesity. Expert Rev Cardiovasc Ther (2010) 0.96
Guidance for the treatment of deep vein thrombosis and pulmonary embolism. J Thromb Thrombolysis (2016) 0.96
Treatment options for venous thromboembolism: lessons learnt from clinical trials. Thromb J (2014) 0.95
Physiological and management implications of obesity in critical illness. Ann Am Thorac Soc (2014) 0.88
Predicting the risk of venous thromboembolism recurrence. Am J Hematol (2012) 0.88
Clinical markers of the hypercoagulable state by rotational thrombelastometry in obese patients submitted to bariatric surgery. Surg Endosc (2013) 0.87
Optimal duration of anticoagulation after venous thromboembolism. Circulation (2011) 0.85
Acute pulmonary embolism. Part 1: epidemiology and diagnosis. Nat Rev Cardiol (2010) 0.85
Longer legs are associated with greater risk of incident venous thromboembolism independent of total body height. The Longitudinal Study of Thromboembolism Etiology (LITE). Thromb Haemost (2011) 0.84
Recurrent venous thromboembolism: what is the risk and how to prevent it. Scientifica (Cairo) (2012) 0.82
Predictors of venous thromboembolism recurrence, adjusted for treatments and interim exposures: a population-based case-cohort study. Thromb Res (2015) 0.81
Body mass index and risk of left atrial thrombus in patients with atrial fibrillation. Am J Cardiol (2009) 0.80
Management of Venous Thromboembolisms: Part I. The Consensus for Deep Vein Thrombosis. Zhonghua Minguo Xin Zang Xue Hui Za Zhi (2016) 0.80
Dosing of unfractionated heparin in obese patients with venous thromboembolism. J Gen Intern Med (2010) 0.80
Epidemiology of recurrent venous thrombosis. Braz J Med Biol Res (2011) 0.78
Thrombotic events in metastatic colorectal cancer patients treated with leucovorin, fluorouracil and irinotican (FOLFIRI) plus bevacizumab. J Gastrointest Oncol (2015) 0.77
Comparison of heparin dosing based on actual body weight in non-obese, obese and morbidly obese critically ill patients. Int J Crit Illn Inj Sci (2013) 0.75
Successful pulmonary endarterectomy in a patient with klinefelter syndrome. Case Rep Pulmonol (2012) 0.75
The effects of obesity on venous thromboembolism: A review. Open J Prev Med (2012) 0.75
Optimal duration of anticoagulation in patients with venous thromboembolism. Indian J Med Res (2011) 0.75
Obesity and clotting: Body mass index independently contributes to hypercoagulability after injury. J Trauma Acute Care Surg (2015) 0.75
Assessing the risk of recurrent venous thromboembolism--a practical approach. Vasc Health Risk Manag (2015) 0.75
Recurrent cerebral venous sinus thrombosis in a patient with increased factor VIII activity, increased lipoprotein (a) level and leukocytosis: a case report. J Vasc Interv Neurol (2014) 0.75
Educational Level, Anticoagulation Quality, and Clinical Outcomes in Elderly Patients with Acute Venous Thromboembolism: A Prospective Cohort Study. PLoS One (2016) 0.75
Venous Thromboembolism Risk and Adequacy of Prophylaxis in High Risk Pregnancy in the Arabian Gulf. Curr Vasc Pharmacol (2016) 0.75
Thrombin generation profiles as predictors of symptomatic venous thromboembolism after trauma: A prospective cohort study. J Trauma Acute Care Surg (2017) 0.75
Obesity is not associated with recurrent venous thromboembolism in elderly patients: Results from the prospective SWITCO65+ cohort study. PLoS One (2017) 0.75
Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med (2012) 11.86
The risk of recurrent venous thromboembolism in men and women. N Engl J Med (2004) 7.41
Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med (2006) 6.51
Lymphoma-specific genetic aberrations in microvascular endothelial cells in B-cell lymphomas. N Engl J Med (2004) 3.63
D-dimer levels and risk of recurrent venous thromboembolism. JAMA (2003) 3.30
The relative benefits of endurance and strength training on the metabolic factors and muscle function of people with type 2 diabetes mellitus. Arch Phys Med Rehabil (2005) 3.17
Does carotid stent cell design matter? Stroke (2008) 3.02
High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS). Blood (2008) 2.97
Drosophila genome-wide obesity screen reveals hedgehog as a determinant of brown versus white adipose cell fate. Cell (2010) 2.91
Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation (2007) 2.80
Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer. Thromb Haemost (2007) 2.56
The sedoheptulose kinase CARKL directs macrophage polarization through control of glucose metabolism. Cell Metab (2012) 2.36
The role of heme oxygenase-1 promoter polymorphisms in human disease. Free Radic Biol Med (2004) 2.27
Venous thrombosis: who should be screened for thrombophilia in 2014? Pol Arch Med Wewn (2013) 2.12
Gender differences in outcome of conservatively treated patients with asymptomatic high grade carotid stenosis. Stroke (2005) 2.10
Kisspeptin-10, a KiSS-1/metastin-derived decapeptide, is a physiological invasion inhibitor of primary human trophoblasts. J Cell Sci (2004) 2.08
Effect of smoking on restenosis during the 1st year after lower-limb endovascular interventions. Radiology (2004) 2.07
Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the Vienna prediction model. Circulation (2010) 2.05
The estimation of average hazard ratios by weighted Cox regression. Stat Med (2009) 1.98
Effects of carbon monoxide inhalation during experimental endotoxemia in humans. Am J Respir Crit Care Med (2004) 1.98
Benefit of atrial septal defect closure in adults: impact of age. Eur Heart J (2010) 1.94
Osteoprotegerin plasma concentrations correlate with severity of peripheral artery disease. Atherosclerosis (2005) 1.94
Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions. Catheter Cardiovasc Interv (2009) 1.90
Simvastatin blunts endotoxin-induced tissue factor in vivo. Circulation (2005) 1.89
Influence of blue-light-filtering intraocular lenses on color perception and contrast acuity. Ophthalmology (2009) 1.86
Hypotension and bradycardia after elective carotid stenting: frequency and risk factors. J Endovasc Ther (2003) 1.85
Uveal and capsular biocompatibility of hydrophilic acrylic, hydrophobic acrylic, and silicone intraocular lenses. J Cataract Refract Surg (2002) 1.83
The short- and long-term benefit in chronic low back pain through adjuvant electrical versus manual auricular acupuncture. Anesth Analg (2004) 1.82
Diet and kidney disease in high-risk individuals with type 2 diabetes mellitus. JAMA Intern Med (2013) 1.78
D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study. J Clin Oncol (2009) 1.78
Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation. JAMA (2006) 1.72
Renal artery PTA and stent implantation: immediate and late clinical and morphological outcome. Wien Klin Wochenschr (2002) 1.69
In vitro and in vivo evaluation of [18F]ciprofloxacin for the imaging of bacterial infections with PET. Eur J Nucl Med Mol Imaging (2004) 1.67
Dental and periodontal status and risk for progression of carotid atherosclerosis: the inflammation and carotid artery risk for atherosclerosis study dental substudy. Stroke (2006) 1.65
Vascular inflammation and percutaneous transluminal angioplasty of the femoropopliteal artery: association with restenosis. Radiology (2002) 1.65
Statin therapy improves cardiovascular outcome of patients with peripheral artery disease. Eur Heart J (2004) 1.64
High D-dimer levels are associated with poor prognosis in cancer patients. Haematologica (2012) 1.62
Heme oxygenase and carbon monoxide initiate homeostatic signaling. J Mol Med (Berl) (2007) 1.60
Antibiotic prophylaxis before surgery vs after cord clamping in elective cesarean delivery: a double-blind, prospective, randomized, placebo-controlled trial. Arch Surg (2011) 1.59
To work in a hospital--a new risk factor for development of venous disease? Wien Klin Wochenschr (2003) 1.57
Qualitative and quantitative assessment of nailfold capillaries by capillaroscopy in healthy volunteers. Vasa (2012) 1.57
Human but not mouse adipogenesis is critically dependent on LMO3. Cell Metab (2013) 1.57
Gamma glutamyltransferase and long-term survival: is it just the liver? Clin Chem (2007) 1.56
Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients. Arterioscler Thromb Vasc Biol (2002) 1.54
Statin use is associated with prolonged survival of renal transplant recipients. J Am Soc Nephrol (2008) 1.54
One-year outcome of percutaneous rotational atherectomy with aspiration in infrainguinal peripheral arterial occlusive disease: the multicenter pathway PVD trial. J Endovasc Ther (2009) 1.53
Flecainide versus ibutilide for immediate cardioversion of atrial fibrillation of recent onset. Eur Heart J (2004) 1.52
The EGF A61G polymorphism is associated with disease-free period and survival in malignant melanoma. J Invest Dermatol (2006) 1.52
[Austrian Guidelines for Prophylaxis of Venous Thromboembolism]. Wien Klin Wochenschr (2007) 1.51
Acute-phase response after stent implantation in the carotid artery: association with 6-month in-stent restenosis. Radiology (2003) 1.51
Side effects of phytoestrogens: a meta-analysis of randomized trials. Am J Med (2009) 1.51
Marburg I polymorphism of factor VII-activating protease and risk of recurrent venous thromboembolism. Thromb Haemost (2006) 1.49
Long-term follow-up of metal-on-metal total hip replacement. J Orthop Res (2007) 1.48
Endovascular revascularization below the knee: 6-month results and predictive value of C-reactive protein level. Radiology (2003) 1.48
Carbon monoxide orchestrates a protective response through PPARgamma. Immunity (2006) 1.47
Polymorphisms of the endothelial nitric oxide synthase gene in breast cancer. Breast Cancer Res Treat (2006) 1.46
The salvage potential of coronary sinus interventions: meta-analysis and pathophysiologic consequences. J Thorac Cardiovasc Surg (2004) 1.45
Restenosis after femoropopliteal PTA and elective stent implantation: predictive value of monocyte counts. J Endovasc Ther (2003) 1.44
Is there improvement of "vascular depression" after carotid artery stent placement? Radiology (2006) 1.44
High dose intermittent ARA-C (HiDAC) for consolidation of patients with de novo AML: a single center experience. Leuk Res (2005) 1.44
Abciximab reduces monocyte tissue factor in carotid angioplasty and stenting. Stroke (2003) 1.43
Long-segment SFA stenting--the dark sides: in-stent restenosis, clinical deterioration, and stent fractures. J Endovasc Ther (2005) 1.42
Beck and back: a paradigm change in coronary sinus interventions--pulsatile stretch on intact coronary venous endothelium. J Thorac Cardiovasc Surg (2007) 1.42
Plaque echolucency is not associated with the risk of stroke in carotid stenting. Stroke (2006) 1.42
Insulin, C-peptide, and restenosis after femoral artery balloon angioplasty in type II diabetic and nondiabetic patients. J Vasc Interv Radiol (2005) 1.42
De novo superficial femoropopliteal artery lesions: peripheral cutting balloon angioplasty and restenosis rates--randomized controlled trial. Radiology (2008) 1.41
Endovascular brachytherapy: restenosis in de novo versus recurrent lesions of femoropopliteal artery--the Vienna experience. Radiology (2005) 1.40
Atorvastatin reduces thrombin generation after percutaneous coronary intervention independent of soluble tissue factor. Thromb Res (2004) 1.39
Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST). Circulation (2007) 1.37
Vitamin D status and its relation to age and body mass index. Horm Res (2006) 1.35
Plasma adiponectin, insulin sensitivity, and subclinical inflammation in women with prior gestational diabetes mellitus. Diabetes Care (2004) 1.32
Inflammation and Carotid Artery--Risk for Atherosclerosis Study (ICARAS). Circulation (2005) 1.32
The need for prognosticators in rheumatoid arthritis. Biological and clinical markers: where are we now? Arthritis Res Ther (2008) 1.30
Insulin resistance is unrelated to circulating retinol binding protein and protein C inhibitor. J Clin Endocrinol Metab (2007) 1.29
Interleukin-13 protects from atherosclerosis and modulates plaque composition by skewing the macrophage phenotype. EMBO Mol Med (2012) 1.28
Systemic effects of low-intensity laser irradiation on skin microcirculation in patients with diabetic microangiopathy. Microvasc Res (2002) 1.28
Approaching clinical proteomics: current state and future fields of application in fluid proteomics. Clin Chem Lab Med (2009) 1.27
Vascular endothelial growth factor gene polymorphisms are associated with prognosis in ovarian cancer. Clin Cancer Res (2007) 1.26
Expression of KLF5 is a prognostic factor for disease-free survival and overall survival in patients with breast cancer. Clin Cancer Res (2006) 1.24